Skip to content
10-K

Annual Report

Medicine Man Technologies, Inc.

0001558370-24-004104

← back to feed
Filed
Mar 27, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 1, 2024 77.44M sh
Shares Diluted FY 2023 · Dec 31, 2023 64.54M sh
Shares Diluted FY 2023 · Dec 31, 2022 53.64M sh
Capex FY 2023 · Dec 31, 2023 $7.87M
Capex restated FY 2023 · Dec 31, 2022 $14.01M
Operating Cash Flow FY 2023 · Dec 31, 2023 $12.2M
Operating Cash Flow restated FY 2023 · Dec 31, 2022 $6.69M
Long Term Debt FY 2023 · Dec 31, 2023 $153.26M
Long Term Debt FY 2023 · Dec 31, 2022 $125.52M
Short Term Debt FY 2023 · Dec 31, 2023 $3.55M
Short Term Debt FY 2023 · Dec 31, 2022 $2.25M
Cash And Equivalents FY 2023 · Dec 31, 2023 $19.25M
Cash And Equivalents FY 2023 · Dec 31, 2022 $38.95M
Stockholders Equity FY 2023 · Dec 31, 2023 $119.29M
Stockholders Equity FY 2023 · Dec 31, 2022 $132.16M
Stockholders Equity FY 2023 · Dec 31, 2021 $133.57M
Current Liabilities FY 2023 · Dec 31, 2023 $55.46M
Current Liabilities FY 2023 · Dec 31, 2022 $47.38M
Total Liabilities FY 2023 · Dec 31, 2023 $238.85M
Total Liabilities FY 2023 · Dec 31, 2022 $190.72M
Current Assets FY 2023 · Dec 31, 2023 $53.67M
Current Assets FY 2023 · Dec 31, 2022 $71.74M
Total Assets FY 2023 · Dec 31, 2023 $358.14M
Total Assets FY 2023 · Dec 31, 2022 $322.88M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.66
Eps Diluted FY 2023 · Dec 31, 2022 −$0.49
Eps Basic FY 2023 · Dec 31, 2023 −$0.66
Eps Basic FY 2023 · Dec 31, 2022 −$0.49
Sga Expense FY 2023 · Dec 31, 2023 $39.92M
Sga Expense restated FY 2023 · Dec 31, 2022 $29.04M
Net Income FY 2023 · Dec 31, 2023 −$34.55M
Net Income FY 2023 · Dec 31, 2022 −$18.47M
Operating Income FY 2023 · Dec 31, 2023 $3.29M
Operating Income FY 2023 · Dec 31, 2022 $12.85M
Gross Profit FY 2023 · Dec 31, 2023 $76.02M
Gross Profit restated FY 2023 · Dec 31, 2022 $80.29M
Revenue FY 2023 · Dec 31, 2023 $172.45M
Revenue FY 2023 · Dec 31, 2022 $159.38M